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ABSTRACTSMethods: All patients attending breast clinic between 1st January 2008 -
31st December 2010 with breast pain only, undergoing mammography,
were assessed. Patients were then divided into the under 50 and over 50
age group for comparison.
Results: 315 patients were assessed, 168 (53%) were under 50 years old
(mean 43). All had clinically normal breasts on examination. Six (3.5%)
patients had indeterminate mammographic abnormalities in the under
50’s age group, versus eight (5%) in the over 50’s group. All had benign
ﬁndings following further investigation. One (0.6%) patient in the under
50’s group had a malignant mammographic abnormality - this was on the
asymptomatic side in a 48 year old. In those patients over 50 years, three
(2%) had malignant abnormalities on mammography, of which two were
conﬁrmed malignancies.
Conclusions:Malignancy is rare in patients under the age of 50 presenting
with pain only. In the setting of a normal clinical examination, routine
mammography is not necessary, and may lead to further unnecessary
investigations and anxiety.
0571: MAJOR BREAST AND AXILLARY SURGERY – FEASIBILITY OF A 23
HOUR PATHWAY
Rachel Clancy, Roger Watkins. Frenchay Hospital, Bristol, UK
Aims: Length of hospital stay for mastectomy patients has declined.
Hospital Episode Statistics data for 2010-11 showed the average length of
stay is still almost four days.Without compromising clinical care the aim of
this study was to evaluate the feasibility and safety of a new pathway
aimed at discharging patients within 24 hours of surgery.
Methods: From December 2008 suitable breast cancer patients requiring
mastectomy and/or major axillary surgery were offered same day admis-
sion and discharge home within 24 hours.
Results: 126 patients (mean age:60; range27-86) were included from 2008-
2011. 99(79%) underwent mastectomy with either axillary node sampling
(ANS) (10), sentinel lymph node biopsy (SNB)(59), axillary node clearance
(ANC)(20) or no axillary procedure (10). 4 (3%) had bilateral mastectomy
with either ANS(1), SNB(2) or no axillary procedure (1). (18%) patients
underwent ANCwith either wide local excision (4), repeat excision (1) or no
breast procedure (18). 97(77%) patients were discharged within 24 hours.
24(19%) were discharged on second day and 4(3%) required a three night
stay. One patient developed ventilatory problems post-operatively requiring
transfer to ITU. None of the 97 patients required unplanned readmission.
Conclusions: Major breast and axillary surgery can be safely performed
with a minimal length of post-operative stay in suitable patients.
0589: ONE-STAGE DELAYED BREAST RECONSTRUCTION USING
STRATTICE AND PERMANENT IMPLANT
Victoria Bonello, Siva Gopalswamy, Sheikh Ahmad. Royal Cornwall
Hospital, Truro, Cornwall, UK
Aim: This case series aims to determine the degree of patient satisfaction
and complication rates associated with a novel method of one-stage
delayed breast reconstruction. Method: Six patients underwent recon-
struction, one of which was bilateral, over an eight-month period.
StratticeTM was used to create a subpectoral/allogenic graft pocket capa-
cious enough to accommodate a permanent implant, hence eliminating
the need for further intervention following the index procedure. The
creation of a neo-inframammary fold was essential to produce a natural
looking result.
A patient satisfaction questionnaire was conducted six months following
the procedure.
The complication rate was determined after review of case notes.
Results: All patients showed satisfaction with the cosmetic outcome and
especially with the ease of return to normal activities. One early post-
operative complication was noted. This involved a small area of poor
wound healing at the site of previous irradiation, necessitating excision of
scar tissue.
Conclusion: This case series has demonstrated that this new technique is
an excellent option for patients wishing to undergo a less extensive form of
delayed reconstruction. It is associated with less tissue disruption than
other reconstructive procedures, hence reducing the length of recovery
and complication rates whilst giving the reconstructed breast a natural
appearance.0600: GYNECOMASTIA: IS IT COST-EFFECTIVE TO INVESTIGATE ALL
PATIENTS IN A FINANCIALLY RESTRAINED NHS?
Habib Tafazal, Hiren Chauhan, Mehboob Mirza. Sandwell General Hospital,
Birmingham, UK
Aim: Gynecomastia is a common condition, with manymen being referred
to the already busy rapid access breast clinic. As surgery for gynecomastia
is classed as non-essential, is it cost-effective to investigate all patients?
Method: Retrospective analysis of 97 patients referred from primary care.
All patients were male, aged 17 to 89 years. The costs of the following
investigations were calculated. Blood tests including LFTs, U&Es, TSH, FSH,
LH, prolactin, testosterone, oestradiol, AFP, HCG and imaging in the form of
mammography and ultrasound.
Results: The cost of a complete set of blood tests for each patient, including
stafﬁng and reagents, totals £35. Mammography and ultrasound cost £110
each. 87% of the patients were investigated with blood tests; the majority
of which were normal. 43% had a mammogram, 52% had an ultrasound.
Neither breast cancer nor endocrine pathology was detected in any cases.
Total cost of the blood tests was £3000; mammography costs were over
£4500.
Conclusions: Investigating all patients may not be cost effective but
a selected combination of tests may be useful. We recommend that blood
tests do not add value towards diagnosis and are an unnecessary additional
cost to the already ﬁnancially restrained NHS.
0649: A COMPLETE AUDIT CYCLE OF PREOPERATIVE SURGICAL SITE
MARKING VERIFICATION CHECKLIST
S. Anwar, R. Kurﬁ, S.S. Rajan, P. Webster, P. Turton, K. Horgan. Department
of Breast Surgery, Leeds General Inﬁrmary, The Leeds Teaching Hospitals NHS
Trust, Leeds, UK
Aims: Correct preoperative surgical site marking is a major patient safety
issue. The aim of this audit was to examine the compliance with preopera-
tive surgical site marking veriﬁcation checklist (PMVC) used at this trust.
Methods: A prospective audit (101-patients) and a re-audit following
staff education (125-patients) examined PMVC for correct written
conﬁrmation of: (a) side and procedure, (b) marking veriﬁcation checks
on ward (checks 1 and 2), and preoperatively in theatre (checks 3 and 4),
(d) safety net signings if any of checks 1-4 were not completed (checks 5
and 6).
Results: All patients had correct side and operation description listed.
Ward documentation for checks 1 and 2 were complete in 100% and 97% in
initial-audit, and in 100% and 98% in re-audit period, respectively. In
theatre documentation for checks 3 and 4were complete in 70% and 48% in
initial-audit, and in 80% and 74% in re-audit period. Further safety net-
checks 5 and 6 were not completed in either case (initial-audit¼58%,
re-audit¼36%). No inadvertent side surgery error occurred in either cohort.
Conclusions: A signiﬁcant improvement in practice was demonstrated
following staff education and regular close audit is necessary to ensure
compliance to PMVC which is pivotal in preventing error.
0664: IMPACT OF PROPHYLACTIC ANTIBIOTICS ON THE INCIDENCE OF
POST-OPERATIVE WOUND INFECTION AND SUBSEQUENT DELAY IN
ADJUVANT THERAPY FOR BREAST CANCER
Dilraj Bilku, Caroline Brammer. Royal Wolverhampton Hospital NHS Trust,
Wolverhampton, West Midlands, UK
Introduction: Breast surgery is considered clean but studies have shown
rates of infection to be 3% to 30%. Wound infection results in the delayed
start of adjuvant breast cancer treatment. We therefore conducted an audit
to analyse compliance with guidelines (SIGN guideline 84,104).
Methods: 68 patients undergoing radiotherapy following wide local
excision for breast cancer across four units were analysed. Data was
extracted from treatment sheets, operation notes and anaesthetic charts.
Results: Antibiotic prophylaxis was administered in 28 patients (41%) of
which six (21%) developed wound infection. No antibiotics were given
in 40 patients (59%) of which 20 (50%) developed wound infection.
There was a delay in the initiation of radiotherapy in 31 patients. In two
patients (7%) the delay was due to wound infection while in ten
patients (32%) the delay was due to wound infection and adjuvant
chemotherapy.
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ABSTRACTSConclusion: Wound infection following breast cancer surgery can have
severe consequences by delaying the start of adjuvant chemo-radiotherapy
and affect the outcome of patient. This audit indicates that prophylactic
antibiotics substantially reduce the risk of post-operativewound infections
in breast surgery and thus avoid delay in start of adjuvant treatment or any
additional operation required for deﬁnitive treatment.
0747: ULTRASOUND MARKING OF THE WIRE-TIP PRIOR TO WIRE
GUIDED WIDE LOCAL EXCISION SHOWS PROMISE IN IMPROVING
OUTCOME FOR IMPALPABLE BREAST CANCER
Andy Kordowicz 1, Susie Flexer 1, David Sapherson 2, Gary
Dyke 1. 1Department of Breast Surgery, Harrogate and District Hospital,
Harrogate, North Yorkshire, UK,; 2Department of Radiology, Harrogate and
District Hospital, Harrogate, North Yorkshire, UK
Aim: We examined whether pre-operative ultrasound marking (PUM) of
the wire-tip improved outcome for women undergoing wire-guided wide
local excision (WLE) of impalpable breast cancer.
Methods: Between 01/2010 and 06/2011, 33 women underwent wire-
guidedWLE in our institution. Via a retrospective analysis of case-notes we
identiﬁed patients who had undergone PUM of the wire-tip. Patient age,
tumour characteristics, operating time, mass of specimen excised and
further procedures (cavity-shave) were recorded.
Results: 12 women underwent PUM of the wire-tip (group a), 21 women
did not (group b). Both groups were well matched for age, histological
grade of tumour and tumour size. The median mass of specimen excised
was 48.5g(range 24-92g) for group a and 57g(range 22-140g) for group
b (p¼0.14). Median operating time was 36.5mins(range 19-52mins) for
group a compared to 41mins(range 24-103mins) for group b (p¼0.01).
None of the patients in group a (0%) required a further cavity-shave
compared with 5 of the patients in group b (24%).
Conclusions: PUM of the wire-tip shows promise as an adjunct in wire-
guided WLE of impalpable breast cancer, reducing the mass of specimen
removed (with obvious aesthetic implications), the operating time, and the
number of repeat procedures to which the patient is subjected.
0782: ANALYSIS OF SOCIAL STATUS AND BREAST CANCER PROGNOSIS
USING WELSH INDEX OF MULTIPLE DEPRIVATION AND ACORN
CLASSIFICATION: DOES A GAP EXIST?
Thomas Micic, Rachel Barnes, Kelvin Gomez. Anuerin Bevan Health Board
Trust, Abergavenny, South Wales, UK
Introduction: There has always been an implied association between poor
health and social deprivation. Our study assessed whether a gap in patient
outcome for breast cancer exists between different strata of society within
a geographical region in Wales.
Methods: A retrospective cohort of 745 breast cancer patients was
recruited using cancer registry data from January 2008 to February 2011.
Welsh Index of Multiple Deprivation (WIMD) along with 4 deprivation
categories from the ACORN classiﬁcation based on patient postcodes were
used as a measure of deprivation. Nottingham Prognostic Index (NPI) was
used as a marker of patient outcome.
Results: Analysis of WIMD demonstrated no correlation with NPI
(coefﬁcient: 0.042, p: 0.25). The incidence of breast cancer was highest
(30%) in the least deprived category of patients (20%-26% for the
remaining categories). The mean NPI score was 3.1 for the least deprived
group (3.2 for other categories). 38% of the least deprived patients had an
excellent prognostic outcome (32%-34% for other categories).11% of the
least deprived patients had a poor prognosis (9%-11% for other
categories).
Conclusions: Our results show no statistically signiﬁcant difference in
either the incidence of breast cancer or outcome from treatment of the
disease between different strata of society.
0858: WHAT DO PATIENTS UNDERSTAND ABOUT OF THE ROLE OF
HOSPITAL STAFF AND INVESTIGATIONS IN BREAST CANCER SERVICES?
Rachel L O'Connell, Edward R St John, Nizar Din, Sidonie Hartridge-
Lambert, Omotayo Johnson. Ashford and St Peter's NHS Foundation Trust,
Surrey, UK
Aims: Patients' should be well-informed on the investigations they
undergo and the roles of individual groups of healthcare professionalsinvolved in their care. The aim of this study was to determine the level of
knowledge in patients presenting to a breast unit.
Methods: Awritten questionnaire was given to new patients in the breast
clinic. Questionnaires were reviewed by two independent assessors.
Results: 120 consecutive patients received the questionnaire; 7 declined
or were unable to complete it. Mean age was 46.8 years, 97% (n¼110)
were female and 89% (n¼101) spoke English as their ﬁrst language. 88%
deﬁned ‘surgeon' correctly whereas ‘radiographer' and ‘radiologist' were
correctly deﬁned by only 19% and 29% respectively. 26% correctly
deﬁned ‘pathologist' and 41% ‘oncologist'. Only 39% of patients could
deﬁne ‘mammogram' and 8% ‘ultrasound'. 21% had an understanding of
a ‘multi-disciplinary team meeting'. Younger patients (age<50 years)
had a worse overall understanding than older patients (36% v 41%
correct, p¼0.017)
Conclusion: The majority of breast clinic patients have a poor under-
standing of the investigations they undergo and the role of medical staff
involved in cancer care. Early education is essential, especially in this group
of patients who may require multiple visits and investigations.
0882: THE ROLE OF AXILLARY ULTRASOUND IN EARLY INVASIVE
BREAST CANCER
Liam Convie, Claire Jones, Carrie Mofﬁtt, Mike Reilly, Janne
Bingham. Altnagelvin Hospital, Londonderry, UK
Aim: Axillary node metastases inﬂuence the management of women with
invasive breast cancer. Guidelines recommend axillary ultrasound for all
patients, with ﬁne needle aspiration (FNA) if abnormal. The study aimwas
to assess axillary ultrasound accuracy in a specialist breast centre.
Methods: All cancer patients with early invasive breast cancer, from
August 2010 to August 2011 inclusively, were identiﬁed. Patient demo-
graphics, axillary ultrasound and histology results were obtained. Mann
Whitney U and Fishers Exact tests were used, with a p value of <0.05
considered signiﬁcant.
Results: 197 patients were identiﬁed; 9 were excluded due to incomplete
data. All had axillary ultrasound; 31.0% were abnormal. 64.0% of abnormal
lesions were malignant histologically. Ultrasound sensitivity and
speciﬁcity were 60.9% and 82.5% respectively. Positive and negative
predictive values were 65.0% and 79.8% respectively. Overall accuracy was
75.0%. The median (IQR) proportion of involved nodes was higher in
those with a positive pre-operative ultrasound (50.0%(14.3-85.7%)
vs.17.5%(8.2-42.5%);p¼0.02), although harvested nodes was similar
(17.0(11.0-23.0)vs.14.0(2.7-30.3);p¼0.22). A lower proportion of patients
with micrometastatic disease (35.7%) had a positive ultrasound compared
to macroscopic nodal disease (85.7%;p¼0.004).
Conclusions: Ultrasound accurately assesses axillary lymph node status.
Routine ultrasound should help avoid excessive axillary surgery.
0897: PREDICTING RESPONSE – THE USE OF NEOADJUVANT
CHEMOTHERAPY IN BREAST CANCER A 5 YEAR REVIEW
Eamon Francis, Aoife Lowery, Giueseppe Gullo, John Crown, James
Geraghty, Denis Evoy, Enda W McDermott. St Vincents University
Hospital, Dublin, Ireland
This study aimed to determine the rate of pCR following neoadjuvant
chemotherapy, identify clinicopathologic factors associated with pCR and
validate the efﬁcacy of a published nomogram (Neoadjuvant) (1) in pre-
dicting pCR .
Data was collected on patients with breast cancer treated with neo-
adjuvant chemotherapy at SVUH from July 2006 to July 2011. Patient
demographics, tumour clinicopathologic parameters and chemothera-
peutic regimens were recorded. Response to neoadjuvant chemotherapy
was assessed radiologically and pathologically. Where sufﬁcient data was
available the Neoadjuvant nomogramwas used to calculate the probability
of pCR. Predictive accuracy was assessed by calculating the area under the
receiver operating characteristic (ROC).
89 patients were treated with neoadjuvant chemotherapy during the
study period. pCR was observed in 14%. Estrogen receptor (ER) negativity
and Her2/neu receptor positivity were signiﬁcantly associated with pCR
(p<0.05). All tumours exhibiting a pCR were invasive ductal carcinomas.
No invasive lobular carcinoma exhibited a pCR to neoadjuvant chemo-
therapy. The ROC of the validated nomogram in our breast cancer pop-
ulation revealed a value of 0.87.
